EW up +0.38% percent Today $EW High is at 124.13 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
EW up +0.38% percent Today $EW High is at 124.13 and the Low 122.91 with current volume of 97,404.

Recent News posted below.

Edwards Lifesciences Corp EW other info.
http://investorshangout.com/Edwards-Lifescien...-EW-50936/

EW Edwards Lifesciences Corp Recent Headline News

Thoratec (THOR) Down to Strong Sell on Growing Headwinds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 12:20PM CST
On Nov 11, 2014, Zacks Investment Research downgraded Thoratec Corp. (THOR) to a Zacks Rank #5 (Strong Sell).
ABMD: 33.49 (-0.11), EW: 124.04 (+1.09), THOR: 28.41 (+0.49), ANGO: 16.87 (-0.11)

Roka Bioscience (ROKA) in Focus: Stock Surges 19.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:11AM CST
Roka Bioscience, Inc. (ROKA) was a big mover last session, as the company saw its shares rise over 19% on the day.
ABMD: 33.49 (-0.11), ROKA: 3.49 (-0.10), EW: 124.04 (+1.09), ANGO: 16.87 (-0.11)

Global Prosthetic Heart Valves Industry
PR Newswire - Mon Nov 10, 5:55PM CST
This report analyzes the worldwide markets for Prosthetic Heart Valves in US$ Million by the following Product Segments: Mechanical valves, and Biological/Tissue valves. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 22 companies including many key and niche players such as -
EW: 124.04 (+1.09)

After Yesterday's Rally of 1.50% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 10, 5:12PM CST
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $122.73 to a high of $124.60. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $123.68 on volume of 681,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 124.04 (+1.09)

Volcano Posts Narrower-than-Expected Q3 Loss, Guides Low - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:10AM CST
Despite Volcano (VOLC) provided disappointing revenue guidance for 2014 on account of expected negative foreign exchange impact, management expects accelerated profitability over the near term.
ABMD: 33.49 (-0.11), VOLC: 10.87 (-0.20), EW: 124.04 (+1.09), ANGO: 16.87 (-0.11)

Strength Seen in DexCom (DXCM): Stocks Gains 14.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:46AM CST
DexCom (DXCM) was a big mover last session, with shares rising over 14% on the day.
ABMD: 33.49 (-0.11), DXCM: 53.62 (-0.39), EW: 124.04 (+1.09), ANGO: 16.87 (-0.11)

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Edwards Lifesciences Is Up 16.7% (EW)
Comtex SmarTrend(R) - Mon Nov 10, 8:09AM CST
Two weeks ago on October 23rd, 2014 Edwards Lifesciences (NYSE:EW) reported earnings and analysts, on average, expected earnings of $0.72 on sales of $546.0 million. Edwards Lifesciences actually reported earnings of $0.80 per share on sales of $607.4 million, beating EPS estimates by $0.08 and beating revenue estimates by $61.4 million. Shares of Edwards Lifesciences have climbed from $105.19 to $122.76, representing a gain of 16.7% since the company reported earnings 18 days ago.
EW: 124.04 (+1.09)

Edwards Lifesciences To Present At Credit Suisse 2014 Healthcare Conference
PR Newswire - Fri Nov 07, 12:59PM CST
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Credit Suisse 2014 Healthcare Conference at the Arizona Biltmore in Phoenix on Tuesday, November 11, 2014.
EW: 124.04 (+1.09)

Shares of EW Up 15.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 9:17AM CST
SmarTrend identified an Uptrend for Edwards Lifesciences (NYSE:EW) on October 23rd, 2014 at $106.16. In approximately 2 weeks, Edwards Lifesciences has returned 15.30% as of today's recent price of $122.40.
EW: 124.04 (+1.09)

Downgrade Alert for Edwards Lifesciences (EW)
Comtex SmarTrend(R) - Fri Nov 07, 6:57AM CST
Edwards Lifesciences (NYSE:EW) was downgraded from Buy to Neutral at Sterne Agee today. The stock closed yesterday at $123.57 on volume of 784,000 shares, below average daily volume of 936,000. Edwards Lifesciences share prices have moved between a 52-week high of $123.68 and a 52-week low of $60.62 and closed yesterday at 104% above that low price at $123.57 per share. Over the last five market days, the 200-day moving average (MA) has gone up 1.2% while the 50-day MA has advanced 1.8%.
EW: 124.04 (+1.09)

Insider Trading Alert - EW, SLAB And LCI Traded By Insiders
at The Street - Thu Oct 30, 10:45AM CDT
Stocks with insider trader activity include EW, SLAB and LCI
LCI: 48.20 (-1.53), SLAB: 45.23 (-0.54), EW: 124.04 (+1.09)

Look for Shares of Edwards Lifesciences to Potentially Pullback after Yesterday's 1.45% Rise
Comtex SmarTrend(R) - Wed Oct 29, 4:26PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $118.01 to a high of $120.12. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $118.84 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 124.04 (+1.09)

Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly
PR Newswire - Wed Oct 29, 7:35AM CDT
Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), AbbVie Inc. (NYSE: ABBV), Edwards Lifesciences Corp. (NYSE: EW) and Eli Lilly and Co. (NYSE: LLY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7520-100free.
GILD: 104.13 (-2.77), PFE: 30.35 (-0.07), EW: 124.04 (+1.09), LLY: 67.56 (+0.16), ABBV: 63.52 (-0.24)

IDEXX Tops Q3 Earnings and Revenues; Guidance Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:10PM CDT
Since the news release, IDEXX's (IDXX) share price has climbed 9.8% to eventually close at $138.76 yesterday.
ATEC: 1.39 (-0.03), EW: 124.04 (+1.09), IDXX: 152.42 (-0.46), ANGO: 16.87 (-0.11)

Morning Analysis on Health Care Equipment Stocks - Zimmer Holdings, Edwards Lifesciences, Varian Medical Systems, CareFusion, and Baxter Intl.
PR Newswire - Tue Oct 28, 7:35AM CDT
Investor-Edge has initiated coverage on the following equities: Zimmer Holdings Inc. (NYSE: ZMH), Edwards Lifesciences Corporation (NYSE: EW), Varian Medical Systems Inc. (NYSE: VAR), CareFusion Corporation (NYSE: CFN), and Baxter International Inc. (NYSE: BAX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, October 27, 2014, the NASDAQ Composite ended at 4,485.93, up 0.05%, the Dow Jones Industrial Average edged 0.07% higher to finish the day at 16,817.94, and the S&P 500 closed at 1,961.63, down 0.15%. The gains were broad based as six out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 755.35, up 0.12%, with the index also advancing 5.54% in the previous three months. Register for your complimentary reports on these five stocks at:
ZMH: 110.43 (-0.44), VAR: 88.61 (+1.21), BAX: 72.11 (+0.78), CFN: 57.63 (+0.07), EW: 124.04 (+1.09)

Can the Rally in Edwards Lifesciences (EW) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 6:48AM CDT
Can the Rally in Edwards Lifesciences (EW) Shares Continue?
EW: 124.04 (+1.09)

Critical Alerts For petroleo brasileiro, SodaStream, Edwards Lifesciences, Micron and Starbucks Released By InvestorsObserver
PR Newswire - Mon Oct 27, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for PBR, SODA, EW, MU and SBUX.
SBUX: 77.73 (-0.12), MU: 32.89 (-0.02), PBR: 10.14 (-0.42), EW: 124.04 (+1.09), SODA: 21.72 (+0.20)

Edwards Lifesciences (EW) Worth Watching: Stock Up 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:25AM CDT
Edwards Lifesciences (EW) was a big mover last session, with shares rising 11% on the day.
BABY: 34.42 (-0.12), PACB: 6.92 (+0.17), EW: 124.04 (+1.09), ANGO: 16.87 (-0.11)

SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 11.00% Gain
Comtex SmarTrend(R) - Fri Oct 24, 3:53PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $113.22 to a high of $117.94. Yesterday, the shares gained 11.0%, which took the trading range above the 3-day high of $107.87 on volume of 2.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 124.04 (+1.09)

Stocks Hold Near Session Highs; Drugmakers Shine Again
at Investor's Business Daily - Fri Oct 24, 1:50PM CDT
Stocks looked poised to end the week on a positive note Friday. The Dow Jones industrial average added 0.6%; the S&P 500 rose 0.5% and the Nasdaq picked up 0.4%. NYSE was tracking lower than Thursday's level. Nasdaq volume was tracking close to...
AMZN: 315.48 (+3.97), SYNA: 61.92 (-1.27), EW: 124.04 (+1.09), SLXP: 96.78 (+1.23), MTX: 76.16 (-0.83), CELG: 107.00 (-1.25), GILD: 104.13 (-2.77), JAZZ: 172.93 (-0.60), ALXN: 192.06 (-1.63), PG: 88.87 (-0.61), CTCT: 34.71 (-0.29)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Interventional Ophthalmology: Early Eye Care Strategies Evolve

Updated Category News Views 1

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Continue Reading
Jixingfeng Advances Smart Manufacturing for Socks Market

Updated Category News Views 3

Socks Evolve: From Feet Covers to Tech Gear Once upon a time, socks were merely foot covers, destined to vanish beneath pants and shoes. But not anymore. In the bustling halls of the sock world, Jixingfeng built up a robust repertoire of producing high-performance hosiery for a modern market that demands more than just warmth. They’ve turned socks into a tech-infused...

Continue Reading
Advenica: Rising Star in Secure File Transfer Market

Updated Category News Views 0

Advenica's Ascent in Secure File Transfer The cybersecurity world never sleeps, and with the rapid pace of digital threats, it's no surprise that secure file transfer solutions are becoming hotter commodities than coffee pots on Wall Street. Advenica, a name that might not ring a bell for everyone, has emerged as an 'Emerging Leader' in MarketsandMarkets' latest...

Continue Reading
Moonlock: Award-Winning Design Elevates Cybersecurity's Importance

Updated Category News Views 2

Design Excellence Meets Cybersecurity There's a new sheriff in town when it comes to cybersecurity design, and its name is Moonlock. MacPaw's antivirus and protection app pulled off a coup by bagging the 2026 Red Dot Award in the Interface & User Experience Design category. It's a big deal in the cybersecurity realm, where functionality often overshadows finesse. But...

Continue Reading
Automotive ECU Market Aims $160B by 2033

Updated Category News Views 1

Automotive ECUs Under the Spotlight Picture this: By 2033, the automotive ECU market is expected to balloon to a whopping $160.59 billion. That's some serious cash, and it ain't just pocket change. This $47 billion jump from 2026 isn't just happening by accident—it's got everything to do with high-octane changes in the industry. With a 5.1% CAGR, you best believe it's a...

Continue Reading
Cultural Convergence: Ordos Event Captivates Global Visitors

Updated Category News Views 0

Ordos: Where Cultures Connect Seamlessly Spanning continents and cultures, the recent 'Warm City' event in Ordos, Inner Mongolia, drew international attention like bees to honey. Now, if you're thinking this is just another cultural shindig, think again. François Tchiegue, an ambassador of China-Africa cultural exchanges, described it best when he noted how the morin...

Continue Reading
Papa John's Faces Investor Lawsuit: Class Action Looms

Updated Category News Views 0

Papa John's in Hot Water Again? Look, just when you think the pizza game is all dough and cheesy goodness, along comes a legal scuffle to toss our assumptions. Bronstein, Gewirtz & Grossman, LLC has slapped a class action lawsuit against Papa John's International, Inc. (NASDAQ: PZZA), claiming the company and some of its higher-ups haven't been playing fair with the...

Continue Reading
Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 3

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 3

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 4

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading

Top 5 Most Recently Viewed Articles

Mixed Market Performance in Germany's Stock Exchange Today

Updated Category News Views 328

Understanding Germany's Stock Market Trends Germany's stock market exhibited a mixed performance, showcasing a blend of activity among various sectors. The end of the trading day revealed some interesting shifts, particularly with indices such as the DAX taking a slight downturn while others showed resilience and growth. Despite a slight decline of 0.18% in the DAX,...

Continue Reading
Medicaid Members in Oswego County Get Tailored Nutrition

Updated Category News Views 11

Partnership Forged for Nutritional Health When you hear about new partnerships sprouting up, the first question that sometimes hits your brain is, "What's the angle here?" But this one's got a solid foundation in something even the shrewdest traders can appreciate: real-world impact. Umoja Food For Health has teamed up with Oswego County Opportunities (OCO), aiming to...

Continue Reading
S&T Bancorp Welcomes Stephanie N. Doliveira to Its Board

Updated Category News Views 199

Introduction of Stephanie N. Doliveira S&T Bancorp, Inc. (NASDAQ: STBA), the holding company for S&T Bank, is thrilled to announce the appointment of Stephanie N. Doliveira to its board of directors. Doliveira brings an impressive background of over 25 years in leading initiatives that prioritize people and performance, making her a substantial addition to S&T's...

Continue Reading
NVE Corporation Shares Q3 Financials and Dividend Details

Updated Category News Views 137

NVE Corporation Reports Third Quarter Financial Results NVE Corporation (NASDAQ: NVEC) has recently shared its financial results for the quarter that ended on December 31. The company announced some significant changes that could affect shareholders and analysts alike. Financial Overview This quarter, NVE's total revenue dropped by 25%, amounting to $5.06 million compared...

Continue Reading
Spirit Airlines Commemorates 33 Years with Flight Giveaways

Updated Category News Views 242

Spirit Airlines Celebrates 33rd Anniversary with Exciting Giveaway Spirit Airlines, a leader in affordable air travel, is marking a significant milestone with an exciting initiative for its devoted customers. The airline, which has transformed the way travelers view budget-friendly flights, is commemorating its 33rd anniversary by inviting its loyal supporters to...

Continue Reading